Witnessing the stock’s movement on the chart, on October 26, 2020, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) had a quiet start as it plunged -25.00% to $3.90. During the day, the stock rose to $4.47 and sunk to $3.72 before settling in for the price of $5.20 at the close. Taking a more long-term approach, BVXV posted a 52-week range of $3.60-$62.00.
Meanwhile, its Annual Earning per share during the time was -19.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 0.40%. This publicly-traded company’s shares outstanding now amounts to $10.84 million, simultaneously with a float of $6.93 million. The organization now has a market capitalization sitting at $327.29 million. At the time of writing, stock’s 50-day Moving Average stood at $37.37, while the 200-day Moving Average is $22.92.
BiondVax Pharmaceuticals Ltd. (BVXV) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. BiondVax Pharmaceuticals Ltd.’s current insider ownership accounts for 41.28%, in contrast to 4.20% institutional ownership.
BiondVax Pharmaceuticals Ltd. (BVXV) Earnings and Revenue Records
As on 6/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$1.14 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.01) by -$1.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
BiondVax Pharmaceuticals Ltd.’s EPS increase for this current 12-month fiscal period is 0.40% and is forecasted to reach -0.06 in the upcoming year.
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Trading Performance Indicators
Let’s observe the current performance indicators for BiondVax Pharmaceuticals Ltd. (BVXV). It’s Quick Ratio in the last reported quarter now stands at 6.50. The Stock has managed to achieve an average true range (ATR) of 5.10.
In the same vein, BVXV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.05, a figure that is expected to reach -0.01 in the next quarter, and analysts are predicting that it will be -0.06 at the market close of one year from today.
Technical Analysis of BiondVax Pharmaceuticals Ltd. (BVXV)
Going through the that latest performance of [BiondVax Pharmaceuticals Ltd., BVXV]. Its last 5-days volume of 6.44 million indicated improvement to the volume of 0.23 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 16.86% While, its Average True Range was 6.20.
Raw Stochastic average of BiondVax Pharmaceuticals Ltd. (BVXV) in the period of the previous 100 days is set at 0.51%, which indicates a major fall in contrast to 0.75% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 809.62% that was higher than 349.91% volatility it exhibited in the past 100-days period.